InvestorsHub Logo
Followers 125
Posts 8192
Boards Moderated 2
Alias Born 02/20/2006

Re: midastouch017 post# 461

Sunday, 10/25/2020 4:19:26 AM

Sunday, October 25, 2020 4:19:26 AM

Post# of 651
Dr. Babecoff continued, "We have developed expertise and IP in pursuit of our goals, and we retain a state-of-the-art manufacturing facility. Going forward, we will examine options to maximize the value of these assets." $BVXV

https://www.prnewswire.com/news-releases/biondvax-announces-topline-results-from-phase-3-clinical-trial-of-the-m-001-universal-influenza-vaccine-candidate-301158876.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BVXV News